Leadership
The Vanderbilt-Ingram Cancer Center is led by a director, a deputy director, a chief executive officer and team of associate center directors representing all aspects of the Center. A Cancer Clinical Enterprise Committee oversees strategy and decision-making for the clinical operations of the center. Vanderbilt-Ingram Cancer Center is also guided by a volunteer community Board of Overseers and external scientific advisory board.
- Jennifer A. Pietenpol, Ph.D.
Director
B.F. Byrd Jr. Professor of Molecular Oncology
Professor of Biochemistry, Cancer Biology, and Otolaryngology - David H. Johnson, M.D.
Deputy Director
Cornelius Abernathy Craig Professor of Oncology
Director, Division of Hematology/Oncology
Professor of Medicine - Beth Price, MBA
Chief Executive Officer
Associate Center Directors & Other Key Leaders
- Carlos Arteaga, M.D.
Leader, Breast Cancer Specialized Program of Research Excellence
Vice Chancellor's Chair in Breast Cancer Research
American Cancer Society Clinical Research Professor
Professor of Medicine and Cancer Biology - Dan Beauchamp, M.D.
Associate Director for Clinical/Translational Programs
John Clinton Foshee Distinguished Professor of Surgery
Chair of the Section of Surgical Sciences
- Bettina Beech, Ph.D.
Associate Director for Health Disparties Research, VICC
Associate Professor of Medicine (General Internal Medicine & Public Health) and Surgery
- Bill Blot, Ph.D.
Associate Director for Cancer Prevention, Control and Population-based Research
Professor - David Carbone, M.D., Ph.D.
Harold L. Moses Chair in Cancer Research
Director of Specialized Program of Research Excellence in Lung Cancer - Robert Coffey, M.D.
Ingram Professor of Cancer Research
Prof Med (GI/Med Oncology) & Cell and Developmental Biology
- Carol Eck
Administrator, Cancer Patient Care Center - Debra L. Friedman, M.D.
Interim Director, Pediatric Hematology-Oncology
Interim Director, Vanderbilt Childhood Cancer Program - Scott Hiebert, Ph.D.
Associate Director for Basic Research
Professor
- Beth Jones, M.A.
Executive Director of Development - Mark Kelley, M.D.
Chair, Cancer Committee
Director, Division of Surgical Oncology - Mary Kiger
Associate Director, Business Development - Mark Magnuson, Ph.D.
Director, Vanderbilt Center for Stem Cell Biology
Professor of Molecular Physiology and Biophysics
Professor of Medicine
Professor of Cell and Developmental Biology - Arnold Malcolm, M.D.
Interim Chair, Department of Radiation Oncology - Cynthia F. Manley, B.S.
Associate Director for Communications and Marketing - Susan Mills
Associate Director for Cancer Center Support Grant Administration and Research Initiatives - Barbara Presogna, B.S.
Associate Director for Special Initiatives - Ann Richmond, Ph.D.
Associate Director for Research Education - Anne Washburn, M.P.H.
Associate Director for Patient and Community Education - Elizabeth Williams, Ph.D.
Associate Director Diversity and Minority Affairs
